ZDV therapeutic potential in HCC is closely related to its ability to modulate ABCC5 expression, influencing cellular responses to nucleoside-based drugs and potentially inhibiting tumor growth. The gene discussed is ABCC5; the disease is hepatocellular carcinoma.